Trial · NCT01751906
Trial comparisons20
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 20 of 20
Download this page as JSON| Comparison | Source |
|---|---|
| Absorb BVS vs XIENCE: Number of Cardiac Death/All MI | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With Powered Secondary Endpoint: All Revascularization | Trial comparisons |
| Absorb BVS vs XIENCE: Landmark Analysis on TLF and Components | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Death (Cardiac, Vascular, Non-cardiovascular) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With Powered Secondary Endpoint: Ischemia Driven Target Vessel Revascularization (ID-TVR) | Trial comparisons |
| Absorb BVS vs XIENCE: Acute Success: Procedural Success (Subject Level Analysis) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With Target Vessel Failure (TVF) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With All Target Lesion Revascularization (TLR) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With All Revascularization | Trial comparisons |
| Absorb BVS vs XIENCE: Landmark Analysis on TLF and Components | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With Powered Secondary Endpoint: Angina | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Death/All MI/All Revascularization (DMR) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With All Myocardial Infarction (MI) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Cardiac Death/TV-MI/ID-TLR (TLF) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Cardiac Death/TV-MI/ID-TLR (TLF) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With All Target Vessel Revascularization (TVR) Excluding Target Lesion Revascularization (TLR) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Cardiac Death/All MI/ID-TLR (Major Adverse Cardiac Events-MACE) | Trial comparisons |
| Absorb BVS vs XIENCE: deaths from any cause | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Death/All MI | Trial comparisons |
| Absorb BVS vs XIENCE: serious adverse events | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01751906/comparisons